Clinical trial Recruiting at 1 site Interventional Ages 18 and up

A team-based approach to improve hypertension control

Official title: E3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension Control

Run by Rush University Medical Center · NCT06899750 · Data updated 2026-11-12

This study is testing a new team-based approach to help African American and Latinx patients in Chicago better manage their high blood pressure by combining medical care with community support.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorRush University Medical Center
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedFebruary 10, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedOctober 15, 2026
Trial IDNCT06899750 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are African American and/or Latinx adults aged 18 and older with uncontrolled stage 2 hypertension who are patients at Rush primary care clinics.

Probably not a fit

Patients with organ transplants, those on dialysis, or individuals already participating in another remote hypertension monitoring program may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares a multidisciplinary intervention aimed at addressing both clinical and social needs for hypertension management against enhanced standard care in primary care clinics. It focuses on the unique challenges faced by African American and Latinx populations in Chicago, particularly on the West Side, where significant health disparities exist. The intervention includes remote monitoring and education programs tailored to the specific needs of the community, with the goal of improving hypertension control outcomes. By integrating clinical care with community resources, the study aims to reduce the life expectancy gap related to cardiovascular disease in this region.

Why it matters

Potential benefit: If successful, this approach could significantly improve hypertension management and health outcomes for underserved populations.

How similar studies have gone: Other studies have shown success with multidisciplinary approaches to hypertension management, particularly in addressing social determinants of health.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults 18 years or older
* African American and/or Latinx
* Uncontrolled stage 2 hypertension, BP \>/= 140/90
* Patient is following with Rush primary care provider in eligible Rush primary care clinics
* Patient has a smart phone (Android or iOS)
* Patient has an email

Exclusion Criteria:

* Organ transplant recipient
* On dialysis
* Patient is already participating in another remote hypertension monitoring program
* Patient is not interested in participating in the program
* Patient has already participated in the E3 Hypertension program or the E3 Diabetes program

Where it's running

  • Rush University Medical Center
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.